Adult Attention-Deficit/Hyperactivity Disorder (ADHD) presents a significant challenge for individuals and their support networks. While behavioral therapies play a crucial role, pharmacological interventions often augment these strategies to effectively manage symptoms. This review investigates the current landscape of medications approved for adu